It helps regulate blood sugar by stimulating insulin release, inhibiting glucagon secretion, and slowing gastric emptying
Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose
(3) diagnosis with disorders of the retina before the diagnosis of type 2 diabetes (Additional file 1: Table S5)
[DOI] [PubMed] [Google Scholar] [53].Rosenstock J, Raccah D, Koranyi L, Maffei L, Boka G, Miossec P, Gerich JE, Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X), Diabetes care, 36 (2013) 29452951
Well reach back out with a free digital treatment recommendation personalized to your needs!